Mazar Andrew Paul has filed 3 insider transactions across 1 company since April 2025.
Most recent transaction: a grant/award of 105000 shares of ACTUATE THERAPEUTICS, INC. ($ACTU) on April 01, 2026.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| April 1, 2026 | ACTUATE THERAPEUTICS, INC. | $ACTU | Mazar Andrew Paul | Chief Operating Officer | A | Employee Stock Option (right to buy) | 105000 | $0.00 | 105,000.0000 | 23,243,328 | 9999.99% | 0.45% |
| April 1, 2025 | ACTUATE THERAPEUTICS, INC. | $ACTU | Mazar Andrew Paul | Chief Operating Officer | A | Employee Stock Option (right to buy) | 51046 | $0.00 | 51,046.0000 | 19,531,636 | 9999.99% | 0.26% |
| April 1, 2025 | ACTUATE THERAPEUTICS, INC. | $ACTU | Mazar Andrew Paul | Chief Operating Officer | A | Employee Stock Option (right to buy) | 110346 | $0.00 | 110,346.0000 | 19,531,636 | 9999.99% | 0.56% |